| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| CDMO(元) | 27,811,600.00 | 80,320,700.00 | 59,198,619.72 | 153,742,916.52 |
| 标准肝素原料(元) | 290,750,600.00 | 787,139,800.00 | 532,521,159.44 | 997,326,413.18 |
| 制剂(元) | 1,658,715,100.00 | 3,050,268,300.00 | 1,547,734,824.15 | 2,771,665,012.18 |
| 营业成本(元) | ||||
| CDMO(元) | 14,218,500.00 | 27,401,500.00 | 34,809,870.04 | 99,444,679.61 |
| 标准肝素原料(元) | 197,847,100.00 | 548,717,100.00 | 377,951,044.62 | 661,927,692.42 |
| 制剂(元) | 1,022,077,200.00 | 1,646,021,100.00 | 865,110,972.64 | 1,260,714,461.78 |
| 毛利(元) | ||||
| CDMO(元) | 13,593,100.00 | 52,919,200.00 | 24,388,749.68 | 54,298,236.91 |
| 标准肝素原料(元) | 92,903,500.00 | 238,422,700.00 | 154,570,114.82 | 335,398,720.76 |
| 制剂(元) | 636,637,900.00 | 1,404,247,200.00 | 682,623,851.51 | 1,510,950,550.40 |
| 毛利率(%) | ||||
| CDMO(%) | 48.88 | 65.88 | 41.20 | 35.32 |
| 标准肝素原料(%) | 31.95 | 30.29 | 29.03 | 33.63 |
| 制剂(%) | 38.38 | 46.04 | 44.10 | 54.51 |
| 收入构成(%) | ||||
| CDMO(%) | 1.41 | 2.05 | 2.77 | 3.92 |
| 标准肝素原料(%) | 14.70 | 20.09 | 24.89 | 25.42 |
| 制剂(%) | 83.89 | 77.86 | 72.34 | 70.66 |
| 毛利构成(%) | ||||
| CDMO(%) | 1.83 | 3.12 | 2.83 | 2.86 |
| 标准肝素原料(%) | 12.50 | 14.06 | 17.94 | 17.65 |
| 制剂(%) | 85.67 | 82.82 | 79.23 | 79.50 |